EUVIMEDEUVIMED entdecken
Crossref

Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay

Gary W Moore, Eleanor Foxton, Sean Platton, Nada Yartey, Danielle White, Stephen G MacDonald

Journal of Thrombosis and Haemostasis · 2023

DOI: 10.1016/j.jtha.2023.08.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Gary W Moore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Natural Sci…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Triple positivity for all 3 criteria antiphospholipid antibodies confers high risk of symptom development in carriers, and recurrence in antiphospholipid syndrome (APS). Most triple-positivity studies report lupus anticoagulant (LA) testing as positive without distinguishing between positivity with dilute Russell's viper venom time (dRVVT) and activated partial thromboplastin time (APTT) and single-assay positivity or only perform dRVVT. Single LA assay repertoires remain in use in some centers, which risks missing some triple positives. Positivity with both assays may identify higher risk. OBJECTIVES: The aim of this study is to investigate the frequency of single LA assay positivity in triple-positive patients. METHODS: Three hundred forty-two triple-positive profiles from nonanticoagulated patients (237 APS, 45 systemic lupus erythematosus without APS symptoms, and 60 nonclinical criteria) were identified from laboratory databases and assessed for LA positivity by dRVVT and/or APTT. RESULTS: Seventy-three of 237 (30.8%) APS samples were LA-positive with 1 assay, 40/237 (16.9%) by dRVVT only, and 33/237 (13.9%) with APTT only. Nineteen of 45 (42.2%) were LA-positive with 1 assay in the systemic lupus erythematosus cohort; 12/45 (26.7%) with dRVVT only and 7/45 (15.5%) with APTT only. Thirty-three of 60 (55.0%) were LA-positive with 1 assay in the nonclinical criteria cohort; 24/60 (40.0%) with dRVVT only and 9/60 (15.0%) with APTT only. The most common solid-phase assay profile was elevated immunoglobulin G aCL and aβ2GPI. CONCLUSION: Up to 55.0% of triple-positive samples were positive in 1 LA assay, representing significant potential for misdiagnosis and inappropriate management via single LA assay repertoires.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeLupus Erythematosus, SystemicHumansLupus Coagulation InhibitorBlood Coagulation TestsAntibodies, AntiphospholipidProthrombin TimePartial Thromboplastin Time

Stichwörter der Autor:innen

activated partial thromboplastin timeantiphospholipid syndromedilute Russell’s viper venom timelupus anticoagulanttriple positive

Substanzen

Lupus Coagulation InhibitorAntibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Natural Sciences, Faculty of Science and Technology, Middlesex University, London…
  • Synnovis Haemostasis and Thrombosis Laboratory, St Thomas' Hospital, London, UK.
  • The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
  • East and South East London NHS Pathology Partnership, Barts Health NHS Trust, London, UK.
  • Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Zitieren

APA

Moore, G. W., Foxton, E., Platton, S., Yartey, N., White, D., & MacDonald, S. G. (2023). Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.08.009

Vancouver

Moore GW, Foxton E, Platton S, Yartey N, White D, MacDonald SG. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.08.009

BibTeX
@article{Moore2023,
  author = {Moore, Gary W and Foxton, Eleanor and Platton, Sean and Yartey, Nada and White, Danielle and MacDonald, Stephen G},
  title = {Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  doi = {10.1016/j.jtha.2023.08.009}
}
Kostenlos starten →